Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-gamma in alopecia areata.

Ercan Arca1, Ugur Muşabak, Ahmet Akar

  • 1Department of Dermatology, Gülhane Military Medical Faculty, School of Medicine Etlik, 06018 Ankara, Turkey. earca@gata.edu.tr

European Journal of Dermatology : EJD
|February 18, 2004
PubMed
Summary

Elevated serum interferon-gamma (IFN-γ) levels are linked to alopecia areata, a common autoimmune hair loss condition. Higher IFN-γ in patients suggests its role in disease inflammation and potential as a prognostic indicator.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coexistence of a Leaky SCID Phenotype With Hyperphenylalaninemia in an Adult Case.

Case reports in immunology·2025
Same author

Correction to: Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye.

Journal of clinical immunology·2024
Same author

Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye.

Journal of clinical immunology·2024
Same author

Efficacy of abatacept treatment in a patient with enteropathy carrying a variant of unsignificance in <i>CTLA4</i> gene: A case report.

World journal of clinical cases·2023
Same author

Compromised T-cell immunity in patients with spinal cord injury and its relationship with injury characteristics.

Turkish journal of physical medicine and rehabilitation·2023
Same author

The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity.

The journal of allergy and clinical immunology. In practice·2022

Area of Science:

  • Immunology
  • Dermatology
  • Autoimmune Diseases

Background:

  • Alopecia areata is a prevalent autoimmune disorder targeting hair follicles.
  • Its pathogenesis involves T-cell mediated inflammation, with a focus on T-helper type 1 cytokines like interferon-gamma (IFN-γ).
  • Understanding cytokine profiles is crucial for diagnosing and managing alopecia areata, including its localized (LAA) and extensive forms (alopecia totalis/universalis - AT/AU).

Purpose of the Study:

  • To compare serum IFN-γ levels in patients with alopecia areata versus healthy controls.
  • To investigate differences in serum IFN-γ levels between localized alopecia areata (LAA) and extensive forms (AT/AU).

Main Methods:

  • Serum samples were collected from 40 patients with alopecia areata and 20 healthy controls.

Related Experiment Videos

  • Patients were categorized into LAA (n=19) and extensive forms (AT/AU, n=21).
  • Interferon-gamma levels were quantified using enzyme immunoassay techniques.

    • Main Results:

    • Serum IFN-γ levels were significantly higher in alopecia areata patients compared to controls (p < 0.05).
    • Both LAA and extensive forms showed significantly elevated IFN-γ levels versus controls (p < 0.05).
    • No significant difference in IFN-γ levels was found between LAA and extensive alopecia areata groups (p > 0.05).

    Conclusions:

    • Elevated serum IFN-γ may indicate inflammatory activity in alopecia areata, particularly in extensive cases.
    • Monitoring serum IFN-γ could aid in distinguishing patients at risk for progression to universalis from localized cases.
    • Targeting IFN-γ production might be a therapeutic strategy for managing alopecia areata.